3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
5
Thyroid Neoplasms
1
Patient Acceptance of Health Care
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Endometrial Neoplasms
1
Carcinoma, Renal Cell
1
Interventions
palbociclib
1
exemestane
1
Vinorelbine
1
Tamoxifen
1
Paclitaxel
1
Letrozole
1
Fulvestrant
1
Epirubicin
1
Drug Therapy
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Patient Acceptance of Health Care
×
palbociclib
×
Clear all
NCT03355157
2024-10-01
PADMA
GBG Forschungs GmbH
Phase 4
Completed
130 enrolled